Blog
-
-
The largest healthcare company in the US is sounding the alarm on a new kind of emergency room that charges 20 times more than a regular doctor visit
-
Louisiana’s ‘Netflix’ deal for hepatitis C drugs wins bids from AbbVie, Gilead and Merck
-
High Deductibles May Threaten Breast Cancer Patients’ Survival
-
Guardant’s blood test might replace biopsies for some lung cancer patients, study says
-
Novartis gene therapy would be cost effective up to $900,000: U.S. group
-
Cervical cancer could be eliminated in most countries by 2100, study finds
-
FDA Fell Short in Preventing Fentanyl Abuse Crisis, Report Claims
-
Immunotherapies could change kidney cancer care, studies suggest
-
CMS unveils CAR-T proposal, with emphasis on patient outcomes